Shockwave Medical (SWAV) Tops Q3 EPS by 39c, Raises FY Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Shockwave Medical (SWAV) PT Raised to $320 at BofA Securities
November 8, 2022 9:17 AM ESTBofA Securities analyst Travis Steed raised the price target on Shockwave Medical (NASDAQ: SWAV) to $320.00 (from $310.00) while maintaining a Buy rating.
"Impressive op margin improvement once again""... More